Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1986 Feb;21(2):231–233. doi: 10.1111/j.1365-2125.1986.tb05181.x

Plasma concentrations of sodium cromoglycate given by nebulisation and metered dose inhalers in patients with exercise-induced asthma: relationship to protective effect.

K R Patel, W M Tullett, M G Neale, R T Wall, K M Tan
PMCID: PMC1400907  PMID: 3082347

Abstract

Plasma sodium cromoglycate (SCG) concentrations were measured in 11 patients at regular intervals before and after exercise in a double-blind study to assess the protective effect in exercise-induced asthma (EIA) of 2, 10 and 20 mg SCG aerosol and placebo, and (on an open basis) nebulised SCG (10 g l-1). There was a dose related increase in plasma concentration and AUC (0-1 h) with the aerosol formulations; values with nebulised SCG were significantly higher than with any aerosol dose. Protection from EIA increased to a maximum of 66% at plasma concentrations of 4 ng ml-1 and above. Thus measurement of plasma concentration can allow a comparison to be made between the protective effects of SCG following different methods of inhalation. It is important to note, however, that plasma concentration per se is almost certainly not related directly to protective effect.

Full text

PDF
231

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brown K., Gardner J. J., Lockley W. J., Preston J. R., Wilkinson D. J. Radioimmunoassay of sodium cromoglycate in human plasma. Ann Clin Biochem. 1983 Jan;20(Pt 1):31–36. doi: 10.1177/000456328302000105. [DOI] [PubMed] [Google Scholar]
  2. Moss G. F., Jones K. M., Ritchie J. T., Cox J. S. Plasma levels and urinary excretion of disodium cromoglycate afer inhalation by human volunteers. Toxicol Appl Pharmacol. 1971 Oct;20(2):147–156. doi: 10.1016/0041-008x(71)90041-x. [DOI] [PubMed] [Google Scholar]
  3. Newman S. P., Pavia D., Clarke S. W. How should a pressurized beta-adrenergic bronchodilator be inhaled? Eur J Respir Dis. 1981 Feb;62(1):3–21. [PubMed] [Google Scholar]
  4. Patel K. R., Berkin K. E., Kerr J. W. Dose-response study of sodium cromoglycate in exercise-induced asthma. Thorax. 1982 Sep;37(9):663–666. doi: 10.1136/thx.37.9.663. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Patel K. R., Kerr J. W. The dose-duration effect of sodium cromoglycate in exercise-induced asthma. Clin Allergy. 1984 Jan;14(1):87–91. doi: 10.1111/j.1365-2222.1984.tb02195.x. [DOI] [PubMed] [Google Scholar]
  6. Tullett W. M., Tan K. M., Wall R. T., Patel K. R. Dose-response effect of sodium cromoglycate pressurised aerosol in exercise induced asthma. Thorax. 1985 Jan;40(1):41–44. doi: 10.1136/thx.40.1.41. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Walker S. R., Evans M. E., Richards A. J., Paterson J. W. The fate of ( 14 C)disodium cromoglycate in man. J Pharm Pharmacol. 1972 Jul;24(7):525–531. doi: 10.1111/j.2042-7158.1972.tb09051.x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES